Tudor Investment Corp
GSK icon

Tudor Investment Corp’s GSK GSK Stock Holding History

Tudor Investment Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,816
Closed -$385K – 2630
2023
Q1 		$385K Buy
+10,816
New +$378K 0.01% 1769
2022
Q4 		– Sell
-23,126
Closed -$681K – 2566
2022
Q3 		$681K Buy
+23,126
New +$876K 0.01% 1178

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tudor Investment Corp's GSK Position: Q2 2023 in Review

Tudor Investment Corp sold out of GSK (GSK) in Q2 2023, closing a stake of 10,816 shares — an estimated $385K sold.

Tudor Investment Corp first reported a position in GSK in Q3 2022 and held it in 2 quarters. The position peaked at $681K in Q3 2022. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • Tudor Investment Corp reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 10,816 GSK shares in Q2 2023, an estimated $385K.
  • Tudor Investment Corp first reported a position in GSK in Q3 2022 and held it in 2 quarters.
  • Tudor Investment Corp's GSK position peaked at $681K in Q3 2022.
  • 828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.